TipRanks
Go Ultimate55% OFF

Anavex Life Sciences (12X1) Balance Sheet

Anavex Life Sciences Balance Sheet

Anavex Life Sciences's total assets for Q3 2026 were $120.14M, a decrease of 6.70% from the previous quarter. DE:12X1 total liabilities were $7.69M for the fiscal quarter, a 8.97% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetSep 25Sep 24Sep 23Sep 22Sep 21
$ 103.81M$ 135.57M$ 154.39M$ 152.70M$ 161.62M
$ 8.95M$ 15.30M$ 12.53M$ 10.21M$ 10.80M
$ 94.87M$ 120.26M$ 141.85M$ 142.49M$ 150.82M

Currency in USD

Anavex Life Sciences Debt to Assets

060M120M180M0 %8 %16 %24 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets